Richard Z. Liu

IPEP: an in silico tool to examine proteolytic peptides for mass spectrometry

Steven Eschrich, Victoria Izumi, John Koomen, 2008, Bioinform..

Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.

Richard Z. Liu, S. Eschrich, S. Altiok, 2011, Journal of proteome research.

Coupling an EML4-ALK–centric interactome with RNA interference identifies sensitizers to ALK inhibitors

Richard Z. Liu, Jihye Kim, A. Tan, 2016, Science Signaling.

Quantification of peptides from immunoglobulin constant and variable regions by LC‐MRM MS for assessment of multiple myeloma patients

Richard Z. Liu, S. Eschrich, J. Teer, 2014, Proteomics. Clinical applications.

JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrations

Richard Z. Liu, Yuan Ren, Jie Wu, 2013, Scientific Reports.

Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry.

Richard Z. Liu, T. Yeatman, M. Gruidl, 2010, Journal of proteome research.

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

Richard Z. Liu, T. Yeatman, S. Eschrich, 2011, Proteomics. Clinical applications.